Chronic obstructive pulmonary disease and Gastrointestinal inflammation

Summary:

Gastrointestinal inflammation is found among people with Chronic obstructive pulmonary disease, especially for people who are male, 60+ old.

The study analyzes which people have Gastrointestinal inflammation with Chronic obstructive pulmonary disease. It is created by eHealthMe based on reports of 30 people who have Chronic obstructive pulmonary disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 18, 2022

30 people who have Chronic Obstructive Pulmonary Disease and Gastrointestinal Inflammation are studied.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 2,646 drugs and 1,967 conditions by eHealthMe.

What is Gastrointestinal inflammation?

Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 774 drugs and 512 conditions by eHealthMe.

Number of Gastrointestinal inflammation in Chronic obstructive pulmonary disease reports submitted per year:

Would you have Gastrointestinal inflammation when you have Chronic obstructive pulmonary disease?

Gender of people who have Chronic Obstructive Pulmonary Disease and experienced Gastrointestinal Inflammation *:

female: 43.33 %
male: 56.67 %

Age of people who have Chronic Obstructive Pulmonary Disease and experienced Gastrointestinal Inflammation *:

Common co-existing conditions for these people *:

Hypersensitivity: 5 people, 16.67%
High Blood Pressure: 5 people, 16.67%
Stress And Anxiety: 3 people, 10.00%
Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 3 people, 10.00%
Asthma: 2 people, 6.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.67%
Hyperchlorhydria (gastric acid levels are higher in stomach): 2 people, 6.67%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 6.67%
Pneumonia: 2 people, 6.67%
Prostatic Disorder: 2 people, 6.67%

Common drugs taken by these people *:

Symbicort: 11 people, 36.67%
Spiriva: 6 people, 20.00%
Serevent: 5 people, 16.67%
Anoro Ellipta: 5 people, 16.67%
Pantoprazole: 5 people, 16.67%
Paroxetine Hydrochloride: 4 people, 13.33%
Tramadol Hydrochloride: 4 people, 13.33%
Flomax: 3 people, 10.00%
Fexofenadine Hydrochloride: 3 people, 10.00%
Humira: 3 people, 10.00%

Common symptoms for these people *:

Muscle Spasms (muscle contraction): 7 people, 23.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 20.00%
Diarrhea: 6 people, 20.00%
Gallbladder Disorder: 5 people, 16.67%
Pancreatic Duct Stenosis (abnormal narrowing of a passage in the pancreatic duct): 5 people, 16.67%
Pancreatitis (inflammation of pancreas): 5 people, 16.67%
Movement - Uncontrolled Or Slow: 5 people, 16.67%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 16.67%
Oesophageal Spasm (contraction of oesophagus): 5 people, 16.67%
Abdominal Discomfort: 5 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gastrointestinal inflammation?

Check whether Gastrointestinal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, "Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn9s disease", Gut, 2016 Mar .

Related studies

Treatments, associated drugs and conditions:

Chronic obstructive pulmonary disease (169,903 reports)
Gastrointestinal inflammation (7,706 reports)

COVID vaccines that are related to Gastrointestinal inflammation:

Common drugs associated with Gastrointestinal inflammation:

Amlodipine: 113 reports
Aspirin: 187 reports
Calcium: 154 reports
Cyclophosphamide: 139 reports
Enbrel: 126 reports
Humira: 2,862 reports
Ibu: 118 reports
Ibuprofen: 125 reports
Imuran: 166 reports
Metformin: 113 reports
Methotrexate: 461 reports
Morphine: 111 reports
Nexium: 143 reports
Omeprazole: 285 reports
Pantoprazole: 207 reports
Pentasa: 133 reports
Prednisone: 611 reports
Remicade: 268 reports
Synthroid: 127 reports
Tramadol: 104 reports
Tylenol: 121 reports
Vitamin b12: 142 reports
Vitamin d: 213 reports

How the study uses the data?

The study is based on Gastrointestinal inflammation and Chronic obstructive pulmonary disease, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.